EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Summary of Viral Targets and Recently Released PDB IDs of SARS-CoV-2

Rohit Bhatia, Raj K. Narang, Ravindra K. Rawal

The Open Virology Journal · 16.04.2020 · 14 (1) · 7-8

DOI: 10.2174/1874357902014010007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Open Virology Journal, erschienen am 16.04.2020. Verfasst von Rohit Bhatia und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug discovery and development against coronavirus disease 2019 is the utmost need and the most challenging task of the hour.Many research groups from different countries are working continuously in this direction, and till 8 th March 2020, a total of 382 clinical trials have been registered on the WHO's International Clinical Trials Registry Platform [1].There is an urgent need to identify specific targets to design promising therapeutic agents against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19.Analysis of SARS-CoV-2 reveals seven major target proteins that can be considered for drug design against the virus.These include the spike, envelope, membrane, nucleocapsid, protease, hemagglutinin esterase and helicase [2,3].Beyond these, several Non Structural Proteins (NSPs) can also be evaluated as targets for drug development [4].There are only a few Protein Data Bank (PDB) Ids available related to SARS-CoV-2 in the RCSB database.Table 1 summarizes recently released PDB Ids (from 5.2.2020 to 25.3.2020)for various SARS-CoV-2 targets [5].The SARS-CoV-2 genome encodes a relatively large number of proteins [6].The PL proteinase and the 3CL protease cleave two polyproteins to release different types of NSPs.Hence the proteases represent a relevant target for designing drugs against SARS-CoV-2.The spike (S) protein helps the virus to enter inside the host and also activates the immune response of the host against the virus through the

Zitieren

APA

Bhatia, R., Narang, R. K., & Rawal, R. K. (2020). A Summary of Viral Targets and Recently Released PDB IDs of SARS-CoV-2. The Open Virology Journal, 14(1), 7-8. https://doi.org/10.2174/1874357902014010007

Vancouver

Bhatia R, Narang RK, Rawal RK. A Summary of Viral Targets and Recently Released PDB IDs of SARS-CoV-2. The Open Virology Journal. 2020;14(1):7-8. doi:10.2174/1874357902014010007

BibTeX
@article{Bhatia2020,
  author = {Bhatia, Rohit and Narang, Raj K. and Rawal, Ravindra K.},
  title = {A Summary of Viral Targets and Recently Released PDB IDs of SARS-CoV-2},
  journal = {The Open Virology Journal},
  year = {2020},
  volume = {14},
  number = {1},
  pages = {7--8},
  doi = {10.2174/1874357902014010007}
}
Kostenlos starten →